The North America Bronchoscopes Market would witness market growth of 6.2% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 360.8 thousand units, showcasing a growth of 8.9% (2019-2022).
Bronchoscope is an endoscopic device used by medical experts to treat problems such as obstruction or growth in the airway or to diagnose abnormalities in the lymph nodes in the lungs, chest, and airway. These devices can detect and diagnose obstructions, chronic obstructive pulmonary diseases (COPD), bronchopulmonary hemorrhage, tumours, airway stenosis, and inflammatory conditions. The growing incidence of multiple respiratory illnesses is the most significant factor favouring market expansion.
The main causes of COPD are long-term asthma, prolonged tobacco smoke exposure, indoor and outdoor air pollution, and occupational fumes and dust. The main end-users of bronchoscopes are clinics, NGOs, private hospitals, and government healthcare facilities, including Primary Health Centres, Community Health Centres, and District Hospitals (DHs).
The market is anticipated to have significant potential due to the rise in clinics and hospitals around the region. In addition, several initiatives are taken by the governments of developing nations to improve healthcare infrastructure in urban and rural areas, which is anticipated to result in enhanced healthcare assistance and the availability of the most advanced technological equipment for consumers. Accordingly, it is anticipated to stimulate the market further.
North America has a relatively high prevalence of respiratory diseases, including COPD, lung cancer, asthma, and infectious respiratory conditions. The market in North America is characterized by its technological advancements, commitment to early disease detection, and the adoption of minimally invasive techniques. These factors, combined with a focus on patient care and advanced healthcare infrastructure, make North America a significant region for bronchoscopes and related respiratory devices.
The US market dominated the North America Bronchoscopes Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,111.7 million by 2030. The Canada market is experiencing a CAGR of 8.6% during (2023 - 2030). Additionally, The Mexico market would a CAGR of 7.6% during (2023 - 2030).
Based on Type, the market is segmented into Flexible (Video, Fiberoptic, Hybrid), and Rigid. Based on Usage, the market is segmented into Reusable, and Disposable. Based on End Use, the market is segmented into Hospitals, and Outpatient Facilities. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Bronchoscopes Market is Predict to reach $4.4 Billion by 2030, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teleflex, Inc., Olympus Corporation, Ambu A/S, Karl Storz SE & Co. KG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Cook Medical, Inc. (Cook Group), Medtronic PLC, Johnson & Johnson, Richard Wolf GmbH (The Richard and Annemarie Wolf Foundation)
By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Usage (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By End Use (Volume, Thousand Units, USD Billion/Million, 2019-2030)
By Country (Volume, Thousand Units, USD Billion/Million, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
